Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 326-350 of 917 matching filings.

Per page
25
Current page
14
8-K File 001-31326

FORM 8-K

Filing date
16 Nov 2018
Reporting date
16 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-224207

PROSPECTUS SUPPLEMENT

Filing date
16 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
02 Oct 2018
Reporting date
02 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
07 Aug 2018
Reporting date
07 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
03 Aug 2018
Reporting date
30 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56243

SCHEDULE 13G

Filing date
26 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2018
Reporting date
06 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
26 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
26 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
26 Jun 2018
Reporting date
21 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
21 Jun 2018
Reporting date
18 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2018
Reporting date
18 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Jun 2018
Reporting date
18 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2018
Reporting date
15 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .